GARDP global network

Based in Geneva, GARDP is committed to carrying out antibiotic R&D in regions heavily affected by drug resistance and to ensuring that approved treatments in our portfolio reach patients in those regions. With our co-founder and alliance partner DNDi, we have a cost-efficient global network.

 

GARDP teams are currently hosted in several locations worldwide through DNDi, including Brazil, India, Japan and Thailand. To advance engagement in Africa, an independent collaborative entity known as DNDi GARDP Southern Africa was established in South Africa in 2018. We will continue to increase our presence in key geographies which support our clinical trials and access activities.

 

Strategic locations

GARDP’s team is strategically located to facilitate partnerships with research and healthcare institutions in India, South Africa, and other countries that are heavily affected by drug resistance. 

Sustainable R&D

GARDP collaborates with R&D institutions around the world, drawing on local expertise and skills and expanding local capacity as needed for current and future clinical research.   

Cost efficiency

An alliance agreement with DNDi enables GARDP to support its team in key regions throughout the world without significant increases in overhead costs.  

GARDP Global Network

GARDP Foundation

Set up as an independent not-for-profit in 2018, GARDP’s headquarters are located in Geneva, Switzerland.

DNDi Latin america (Río de Janeiro)

This office supports GARDP’s work on institutional representation by liaising with pharmaceuticals, research partners, national governments and supranational organizations such as PAHO. It also supports access work.

DNDi GARDP Southern Africa

Established by DNDi and GARDP in 2018 for the implementation of GARDP’s trials in Southern Africa. The team also builds regional networks for advocacy, access and stewardship strategies for antibiotics, including SECURE.

DNDi eastern Africa (Nairobi)

This office assists with GARDP’s work in the region, including clinical trials and studies on neonatal sepsis and sexually transmitted infections.

DNDi South Asia (New Delhi)

This office is responsible for the implementation of GARDP’s activities, including observational studies and pharmaceutical drug development. It develops partnerships to adapt access and stewardship strategies for the regional context.

DNDi South-east Asia (Kuala Lumpur)

This office supports GARDP’s work in the region, including developing new, accessible STI treatments and expanding access to essential antibiotics via SECURE.

DNDi Japan (Tokyo)

This office helps GARDP liaise with Japanese pharmaceuticals, research partners and the Japanese government.

  1. GARDP Foundation

    Set up as an independent not-for-profit in 2018, GARDP’s headquarters are located in Geneva, Switzerland.

  2. DNDi Latin america (Río de Janeiro)

    This office supports GARDP’s work on institutional representation by liaising with pharmaceuticals, research partners, national governments and supranational organizations such as PAHO. It also supports access work.

  3. DNDi GARDP Southern Africa

    Established by DNDi and GARDP in 2018 for the implementation of GARDP’s trials in Southern Africa. The team also builds regional networks for advocacy, access and stewardship strategies for antibiotics, including SECURE.

  4. DNDi eastern Africa (Nairobi)

    This office assists with GARDP’s work in the region, including clinical trials and studies on neonatal sepsis and sexually transmitted infections.

  5. DNDi South Asia (New Delhi)

    This office is responsible for the implementation of GARDP’s activities, including observational studies and pharmaceutical drug development. It develops partnerships to adapt access and stewardship strategies for the regional context.

  6. DNDi South-east Asia (Kuala Lumpur)

    This office supports GARDP’s work in the region, including developing new, accessible STI treatments and expanding access to essential antibiotics via SECURE.

  7. DNDi Japan (Tokyo)

    This office helps GARDP liaise with Japanese pharmaceuticals, research partners and the Japanese government.

3e1a0671

DNDi GARDP Southern Africa

Established by DNDi and GARDP in 2018, this independent organization is responsible for the implementation of GARDP’s trials in Southern Africa. The team also builds regional networks for advocacy, access and stewardship strategies for antibiotics, including SECURE.

GARDP in Japan

GARDP is hosted in Japan by DNDi. This team liaises with Japanese pharmaceuticals, research partners and the Japanese government.